Literature DB >> 8381365

Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor.

N Vita1, P Laurent, S Lefort, P Chalon, X Dumont, M Kaghad, D Gully, G Le Fur, P Ferrara, D Caput.   

Abstract

A human neurotensin receptor (hNTR) cDNA was cloned from the colonic adenocarcinoma cell line HT29. The cloned cDNA encodes a putative peptide of 418 amino acids with 7 transmembrane domains. The amino acid sequence of the hNTR is 84% identical to the rat NTR [Neuron, 4 (1990) 847-854]. Transfection of this cDNA into COS cells results in the expression of receptors with pharmacological properties similar to those found with HT29 cells. Northern blot analysis using the hNTR cDNA probe indicated a single transcript of 4 kb in the brain, the small intestine and blood mononuclear cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381365     DOI: 10.1016/0014-5793(93)81509-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  53 in total

1.  In vitro functional evidence of different neurotensin-receptors modulating the motor response of human colonic muscle strips.

Authors:  T Croci; G Aureggi; F Guagnini; L Manara; D Gully; G L Fur; J P Maffrand; S Mukenge; G Ferla; P Ferrara; P Chalon; N Vita
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

2.  Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression.

Authors:  B M Tyler; K Jansen; D J McCormick; C L Douglas; M Boules; J A Stewart; L Zhao; B Lacy; B Cusack; A Fauq; E Richelson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

3.  Increased ethanol consumption and preference in mice lacking neurotensin receptor type 2.

Authors:  Moonnoh R Lee; David J Hinton; Sencan S Unal; Elliott Richelson; Doo-Sup Choi
Journal:  Alcohol Clin Exp Res       Date:  2010-10-06       Impact factor: 3.455

Review 4.  The role of neurotensin in central nervous system pathophysiology: what is the evidence?

Authors:  Fannie St-Gelais; Claudia Jomphe; Louis-Eric Trudeau
Journal:  J Psychiatry Neurosci       Date:  2006-07       Impact factor: 6.186

5.  Constitutive dimerization of the G-protein coupled receptor, neurotensin receptor 1, reconstituted into phospholipid bilayers.

Authors:  Peter J Harding; Helen Attrill; Jonas Boehringer; Simon Ross; George H Wadhams; Eleanor Smith; Judith P Armitage; Anthony Watts
Journal:  Biophys J       Date:  2009-02       Impact factor: 4.033

6.  Identification of the receptor subtype involved in the analgesic effect of neurotensin.

Authors:  I Dubuc; P Sarret; C Labbé-Jullié; J M Botto; E Honoré; E Bourdel; J Martinez; J Costentin; J P Vincent; P Kitabgi; J Mazella
Journal:  J Neurosci       Date:  1999-01-01       Impact factor: 6.167

7.  High affinity neurotensin receptor mRNA distribution in rat brain and peripheral tissues. Analysis by quantitative RT-PCR.

Authors:  M Méndez; F Souazé; M Nagano; P A Kelly; W Rostène; P Forgez
Journal:  J Mol Neurosci       Date:  1997-10       Impact factor: 3.444

8.  Enhanced tumor retention of NTSR1-targeted agents by employing a hydrophilic cysteine cathepsin inhibitor.

Authors:  Wei Fan; Wenting Zhang; Sameer Alshehri; Trey R Neeley; Jered C Garrison
Journal:  Eur J Med Chem       Date:  2019-05-25       Impact factor: 6.514

9.  Neurotensin modulates pacemaker activity in interstitial cells of Cajal from the mouse small intestine.

Authors:  Jun Lee; Young Dae Kim; Chan Guk Park; Man Yoo Kim; In Yeoub Chang; Dong Chuan Zuo; Pawan Kumar Shahi; Seok Choi; Cheol Ho Yeum; Jae Yeoul Jun
Journal:  Mol Cells       Date:  2012-03-21       Impact factor: 5.034

10.  Neurotensin is an autocrine trophic factor stimulated by androgen withdrawal in human prostate cancer.

Authors:  I Sehgal; S Powers; B Huntley; G Powis; M Pittelkow; N J Maihle
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.